163 related articles for article (PubMed ID: 38840273)
21. Therapeutic ultrasound-enhanced immune checkpoint inhibitor therapy.
Yuan J; Ye D; Chen S; Chen H
Front Phys; 2021 Mar; 9():. PubMed ID: 37994329
[TBL] [Abstract][Full Text] [Related]
22. Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.
Apfelbeck M; Clevert DA; Ricke J; Stief C; Schlenker B
Clin Hemorheol Microcirc; 2018; 69(1-2):93-100. PubMed ID: 29660918
[TBL] [Abstract][Full Text] [Related]
23. Boiling histotripsy and in-situ CD40 stimulation improve the checkpoint blockade therapy of poorly immunogenic tumors.
Singh MP; Sethuraman SN; Miller C; Malayer J; Ranjan A
Theranostics; 2021; 11(2):540-554. PubMed ID: 33391491
[No Abstract] [Full Text] [Related]
24. Focused Ultrasound for Immunomodulation of the Tumor Microenvironment.
Joiner JB; Pylayeva-Gupta Y; Dayton PA
J Immunol; 2020 Nov; 205(9):2327-2341. PubMed ID: 33077668
[TBL] [Abstract][Full Text] [Related]
25. Can pre- and postoperative magnetic resonance imaging predict recurrence-free survival after whole-gland high-intensity focused ablation for prostate cancer?
Rosset R; Bratan F; Crouzet S; Tonoli-Catez H; Mège-Lechevallier F; Gelet A; Rouvière O
Eur Radiol; 2017 Apr; 27(4):1768-1775. PubMed ID: 27436018
[TBL] [Abstract][Full Text] [Related]
26. Magic bubbles: utilizing histotripsy to modulate the tumor microenvironment and improve systemic anti-tumor immune responses.
Imran KM; Ganguly A; Paul T; Powar M; Vlaisavljevich E; Cho CS; Allen IC
Int J Hyperthermia; 2023; 40(1):2244206. PubMed ID: 37580047
[TBL] [Abstract][Full Text] [Related]
27. High-Intensity Focused Ultrasound (HIFU) Triggers Immune Sensitization of Refractory Murine Neuroblastoma to Checkpoint Inhibitor Therapy.
Eranki A; Srinivasan P; Ries M; Kim A; Lazarski CA; Rossi CT; Khokhlova TD; Wilson E; Knoblach SM; Sharma KV; Wood BJ; Moonen C; Sandler AD; Kim PCW
Clin Cancer Res; 2020 Mar; 26(5):1152-1161. PubMed ID: 31615935
[TBL] [Abstract][Full Text] [Related]
28. High-intensity focused ultrasound for prostate cancer.
Napoli A; Alfieri G; Scipione R; Leonardi A; Fierro D; Panebianco V; De Nunzio C; Leonardo C; Catalano C
Expert Rev Med Devices; 2020 May; 17(5):427-433. PubMed ID: 32275187
[TBL] [Abstract][Full Text] [Related]
29. Combination of thermally ablative focused ultrasound with gemcitabine controls breast cancer via adaptive immunity.
Sheybani ND; Witter AR; Thim EA; Yagita H; Bullock TNJ; Price RJ
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32819975
[TBL] [Abstract][Full Text] [Related]
30. [Focused ultrasound therapy: current status and potential applications in neurosurgery].
Dervishi E; Aubry JF; Delattre JY; Boch AL
Neurochirurgie; 2013 Dec; 59(6):201-9. PubMed ID: 24210288
[TBL] [Abstract][Full Text] [Related]
31. Salvage high-intensity focused ultrasound ablation for prostate cancer local recurrence after external-beam radiation therapy: prognostic value of prostate MRI.
Rouvière O; Sbihi L; Gelet A; Chapelon JY
Clin Radiol; 2013 Jul; 68(7):661-7. PubMed ID: 23485154
[TBL] [Abstract][Full Text] [Related]
32. Medium-term Outcomes after Whole-gland High-intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry Cohort.
Dickinson L; Arya M; Afzal N; Cathcart P; Charman SC; Cornaby A; Hindley RG; Lewi H; McCartan N; Moore CM; Nathan S; Ogden C; Persad R; van der Meulen J; Weir S; Emberton M; Ahmed HU
Eur Urol; 2016 Oct; 70(4):668-674. PubMed ID: 26951947
[TBL] [Abstract][Full Text] [Related]
33. Focused Ultrasound Hyperthermia Augments Release of Glioma-derived Extracellular Vesicles with Differential Immunomodulatory Capacity.
Sheybani ND; Batts AJ; Mathew AS; Thim EA; Price RJ
Theranostics; 2020; 10(16):7436-7447. PubMed ID: 32642004
[No Abstract] [Full Text] [Related]
34. Damage effect of high-intensity focused ultrasound on breast cancer tissues and their vascularities.
Guan L; Xu G
World J Surg Oncol; 2016 May; 14(1):153. PubMed ID: 27230124
[TBL] [Abstract][Full Text] [Related]
35. How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer.
Stultz J; Fong L
Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):697-717. PubMed ID: 33820953
[TBL] [Abstract][Full Text] [Related]
36. Clinical and future applications of high intensity focused ultrasound in cancer.
Al-Bataineh O; Jenne J; Huber P
Cancer Treat Rev; 2012 Aug; 38(5):346-53. PubMed ID: 21924838
[TBL] [Abstract][Full Text] [Related]
37. Focused ultrasound tumour ablation in small animal oncology.
Latifi M; Hay A; Carroll J; Dervisis N; Arnold L; Coutermarsh-Ott SL; Kierski KR; Klahn S; Allen IC; Vlaisavljevich E; Tuohy J
Vet Comp Oncol; 2021 Sep; 19(3):411-419. PubMed ID: 34057278
[TBL] [Abstract][Full Text] [Related]
38. Role of Focal Therapy with High-Intensity Focused Ultrasound in the Management of Clinically Localized Prostate Cancer.
Kuru TH; van Essen J; Pfister D; Porres D
Oncol Res Treat; 2015; 38(12):634-8. PubMed ID: 26632846
[TBL] [Abstract][Full Text] [Related]
39. Non-Whole-Gland High-Intensity Focused Ultrasound vs Whole-Gland High-Intensity Focused Ultrasound for Management of Localized Prostate Cancer: 1-Year Oncological and Functional Outcomes.
Lei Y; Zanker P; Yildiz S; Hancke K; Seidl D; Koch O; Schwentner C; Mundhenk J
J Endourol; 2019 Feb; 33(2):100-106. PubMed ID: 30526029
[TBL] [Abstract][Full Text] [Related]
40. T-cell programming in pancreatic adenocarcinoma: a review.
Seo YD; Pillarisetty VG
Cancer Gene Ther; 2017 Mar; 24(3):106-113. PubMed ID: 27910859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]